Part 1. Summary
Part 2. Introduction
· Study period
· Geographical scope
· Market segmentation
Part 3. Pemphigus vulgaris market overview
Part 4. Market breakdown by treatment type
· Biological therapies
· Corticosteroids
· Immunosuppressants
· Intravenous immunoglobulin (IVIG)
· Others
Part 5. Market breakdown by route of administration
· Intravenous
· Oral
· Subcutaneous
Part 6. Market breakdown by end user
· Academic & research institutes
· Hospitals
· Specialty dermatology clinics
Part 7. Market breakdown by region
· North America
· Asia Pacific
· Europe
· Rest of the World (ROW)
Part 8. Key companies
· Almirall, S.A.
· argenx SE
· Biogen Inc.
· F. Hoffmann-La Roche AG
· Novartis AG
· Pfizer Inc.
· Principia Biopharma Inc.
· Sanofi S.A.
· Syntimmune Inc.
Part 9. Methodology